Physician profile

Gregory L Brown

Internal Medicine · Waukesha, WI

NPI 1841344231

$425.80

in general payments reported to CMS, 2019-2025

8 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$137.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $136.54 2019-2022
Pharming Healthcare, INC. $89.11 2023-2024 Ruconest
Abbvie INC. $57.22 2019-2022
Romark Laboratories, Lc $47.61 2019-2020
Exact Sciences Corporation $28.27 2023 Cologuard Collection Kit
Shire North American Group INC $23.60 2019
Alexion Pharmaceuticals, INC. $23.13 2019
Nestle Healthcare Nutrition INC. $20.32 2023

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Gregory L Brown

$425.80

in general payments reported 2019-2025

Years
2019-2024
Top company
Salix Pharmaceuticals, A Division of Bausch Health US, LLC

https://glasscript.com/doctor/614952/gregory-l-brown

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.